Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165542 · ClinicalTrials.gov registry record
A-protein Levels in Adult and Pediatric Brain Tumor Patients
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 54
- Enrollment target
NCT00165542: Completed study, sponsored by Dana-Farber Cancer Institute.
NCT00165542 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00165542 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the sensitivity and specificity of "A-PROTEIN" levels in patients with brain tumors. A-PROTEIN levels will be analyzed both pre and post treatment. Levels in blood and/or cerebrospinal fluid (CSF) will be analyzed and correlated with the underlying diagnosis and outcome.
Primary Outcome
Serum samples were collected when patients were due for clinically indicated phlebotomy. Serum A-PROTEIN levels were determined using a competitive labeled antibody assay and patients were classified into 3 groups: negative \<7pM, equivocal 7-9.9 pM and positive \>/= 10 pM; Clinical status at the same time of the sample collection was established by MRI scans and patients grouped as either resected/decreased versus stable/increased. The relationship between clinical status and A-PROTEIN level wa
Interventions
- OTHER A PROTEIN level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 1998-06 |
| Est. Completion | 2009-08 |
What the finished NCT00165542 record still lists
NCT00165542 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which A PROTEIN level is the first listed.
NCT00165542 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00165542 about?
NCT00165542 is a clinical study titled "A-protein Levels in Adult and Pediatric Brain Tumor Patients". The purpose of this study is to evaluate the sensitivity and specificity of "A-PROTEIN" levels in patients with brain tumors. A-PROTEIN levels will be analyzed both pre and post treatment. Levels in blood and/or cerebrospinal fluid (CSF) will be analyzed and correlated with the underlying diagnosis ...
What is the current status of trial NCT00165542?
This trial is currently completed. The enrollment target is 54 participants. The study started on 1998-06. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00165542?
The interventions under investigation include: A PROTEIN level (OTHER).
Who is sponsoring clinical trial NCT00165542?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia